{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:42:25Z","timestamp":1788252145077,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,2,11]],"date-time":"2016-02-11T00:00:00Z","timestamp":1455148800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Public Health Pol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1057\/jphp.2016.4","type":"journal-article","created":{"date-parts":[[2016,2,11]],"date-time":"2016-02-11T11:58:55Z","timestamp":1455191935000},"page":"200-215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["An overview about the medical use of antifungals in Portugal in the last years"],"prefix":"10.1057","volume":"37","author":[{"given":"Maria","family":"Manuel da S Azevedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cid\u00e1lia","family":"Pina-Vaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ac\u00e1cio","family":"Gon\u00e7alves-Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,11]]},"reference":[{"issue":"7","key":"BFjphp20164_CR1","first-page":"1119","volume":"14","author":"I Faria-Ramos","year":"2014","unstructured":"Faria-Ramos, I. et al (2014) Environmental azole fungicide, prochloraz, can induce cross-resistance to medical triazoles in Candida glabrata. Fems Yeast Research 14 (7): 1119\u20131123.","journal-title":"Fems Yeast Research"},{"issue":"1","key":"BFjphp20164_CR2","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","volume":"125","author":"MA Pfaller","year":"2012","unstructured":"Pfaller, M.A. (2012) Antifungal drug resistance: Mechanisms, epidemiology, and consequences for treatment. American Journal of Medicine 125 (1): S3\u2013S13.","journal-title":"American Journal of Medicine"},{"issue":"1\u20132","key":"BFjphp20164_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.drup.2008.01.001","volume":"11","author":"H Hof","year":"2008","unstructured":"Hof, H. (2008) Is there a serious risk of resistance development to azoles among fungi due to the widespread use and long-term application of azole antifungals in medicine? Drug Resistance Updates 11 (1\u20132): 25\u201331.","journal-title":"Drug Resistance Updates"},{"issue":"2","key":"BFjphp20164_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/fampra\/17.2.145","volume":"17","author":"S Sihvo","year":"2000","unstructured":"Sihvo, S., Ahonen, R., Mikander, H. and Hemminki, E. (2000) Self-medication with vaginal antifungal drugs: Physicians\u2019 experiences and women\u2019s utilization patterns. The Journal of Family Practice 17 (2): 145\u2013149.","journal-title":"The Journal of Family Practice"},{"issue":"4","key":"BFjphp20164_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2174\/157488610792245966","volume":"5","author":"ME Ruiz","year":"2010","unstructured":"Ruiz, M.E. (2010) Risks of self-medication practices. Current Drug Safety 5 (4): 15\u201323.","journal-title":"Current Drug Safety"},{"issue":"2","key":"BFjphp20164_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/10647440400003873","volume":"12","author":"PA M\u00e5rdh","year":"2004","unstructured":"M\u00e5rdh, P.A., W\u00e5gstr\u00f6m, J., Landgren, M. and Holm\u00e9n, J. (2004) Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: I. Analyses of a unique database. Infectious Diseases in Obstetrics and Gynecology 12 (2): 91\u201397.","journal-title":"Infectious Diseases in Obstetrics and Gynecology"},{"issue":"4","key":"BFjphp20164_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.medmal.2013.02.010","volume":"43","author":"L Lelievre","year":"2013","unstructured":"Lelievre, L., Groh, M., Angebault, C., Maherault, A.C., Didier, E. and Bougnoux, M.E. (2013) Azole resistant Aspergillus fumigatus: An emerging problem. Medecine et Maladies Infectieuses 43 (4): 139\u2013145.","journal-title":"Medecine et Maladies Infectieuses"},{"issue":"12","key":"BFjphp20164_CR8","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S1473-3099(09)70265-8","volume":"9","author":"PE Verweij","year":"2009","unstructured":"Verweij, P.E., Snelders, E., Kema, G., Mellado, E. and Melchers, W. (2009) Azole resistance in Aspergillus fumigatus: A side-effect of environmental fungicide use? The Lancet Infectious Diseases 9 (12): 789\u2013795.","journal-title":"The Lancet Infectious Diseases"},{"issue":"June","key":"BFjphp20164_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/1471-2180-14-155","volume":"14","author":"I Faria-Ramos","year":"2014","unstructured":"Faria-Ramos, I. et al (2014) Development of cross-resistance by Aspergillus fumigatus to clinical azoles following exposure to prochloraz, and agricultural azole. BMC Microbiology 14 (June): 155.","journal-title":"BMC Microbiology"},{"key":"BFjphp20164_CR10","doi-asserted-by":"crossref","unstructured":"Vandeputte, P., Ferrari, S. and Coste, A.T. (2012) Antifungal resistance and new strategies to control fungal infections. International Journal of Microbiology 2, doi: 10.1155 2012\/713687.","DOI":"10.1155\/2012\/713687"},{"issue":"S1","key":"BFjphp20164_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1470-9465.2004.00841.x","volume":"10","author":"JA Maertens","year":"2004","unstructured":"Maertens, J.A. (2004) History of the development of azole derivatives. Clinical Microbiology and Infection 10 (S1): 1\u201310.","journal-title":"Clinical Microbiology and Infection"},{"issue":"2","key":"BFjphp20164_CR12","first-page":"130","volume":"19","author":"AJ Carrillo-Munoz","year":"2006","unstructured":"Carrillo-Munoz, A.J., Giusiano, G., Ezkurra, P.A. and Quind\u00f3s, G. (2006) Antifungal agents: Mode of action in yeast cells. Revista espanola de\u00a0quimioterapia 19 (2): 130\u2013139.","journal-title":"Revista espanola de\u00a0quimioterapia"},{"key":"BFjphp20164_CR13","first-page":"728","volume-title":"Medical Microbiology","author":"P Murray","year":"2005","unstructured":"Murray, P., Rosenthal, K. and Pfaller, M.A. (2005) Medical Microbiology, 5th edn. Philadelphia, PA: Elsevier Mosby, pp. 728\u2013730."},{"issue":"4","key":"BFjphp20164_CR14","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/jac\/dki264","volume":"56","author":"C Pina-Vaz","year":"2005","unstructured":"Pina-Vaz, C., Rodrigues, A.G., Costa-de-Oliveira, S., Ricardo, E. and M\u00e5rdh, P.A. (2005) Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by fun-1 staining and flow cytometry. Journal of Antimicrobial Chemotherapy 56 (4): 678\u2013685.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"4","key":"BFjphp20164_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1054\/drup.1999.0090","volume":"2","author":"JR Perfect","year":"1999","unstructured":"Perfect, J.R. and Cox, G.M. (1999) Drug resistance in Cryptococcus neoformans. Drug Resistance Updates 2 (4): 259\u2013269.","journal-title":"Drug Resistance Updates"},{"issue":"1","key":"BFjphp20164_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.05088-11","volume":"56","author":"SM Camps","year":"2012","unstructured":"Camps, S.M. et al (2012) Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: A case study and review of the literature. Antimicrobial Agents and Chemotherapy 56 (1): 10\u201316.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2","key":"BFjphp20164_CR17","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/BF00259685","volume":"227","author":"ME Fling","year":"1991","unstructured":"Fling, M.E., Kopf, J., Tamarkin, A., Gorman, J.A., Smith, H.A. and Koltin, Y. (1991) Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Molecular General Genetics 227 (2): 318\u2013329.","journal-title":"Molecular General Genetics"},{"issue":"10","key":"BFjphp20164_CR18","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1099\/00221287-145-10-2701","volume":"145","author":"P Marichal","year":"1999","unstructured":"Marichal, P. et al (1999) Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology 145 (10): 2701\u20132713.","journal-title":"Microbiology"},{"issue":"4","key":"BFjphp20164_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.diagmicrobio.2009.11.006","volume":"66","author":"F Morio","year":"2010","unstructured":"Morio, F., Loge, C., Besse, B., Hennequin, C. and Pape, P. (2010) Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: New substitutions and a review of the literature. Diagnostic Microbiology and Infectious Disease 66 (4): 373\u2013384.","journal-title":"Diagnostic Microbiology and Infectious Disease"},{"issue":"4","key":"BFjphp20164_CR20","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1128\/AAC.05720-11","volume":"56","author":"LA Vale-Silva","year":"2012","unstructured":"Vale-Silva, L.A. et al (2012) Azole resistance by loss of function of the sterol delta(5),(6)-desaturase gene (ERG3) in Candida albicans does not necessarily decrease virulence. Antimicrobial Agents and Chemotherapy 56 (4): 1960\u20131968.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"9","key":"BFjphp20164_CR21","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1093\/jac\/dks186","volume":"67","author":"F Morio","year":"2012","unstructured":"Morio, F., Pagniez, F., Lacroix, C., Miegeville, M. and Le Pape, P. (2012) Amino acid substitutions in the Candida albicans sterol delta5,6-desaturase (Erg3p) confer azole resistance: Characterization of two novel mutants with impaired virulence. Journal of Antimicrobial Chemotherapy 67 (9): 2131\u20132138.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"4","key":"BFjphp20164_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.diagmicrobio.2009.11.006","volume":"66","author":"F Morio","year":"2010","unstructured":"Morio, F., Loge, C., Besse, B., Hennequin, C. and Le Pape, P. (2010) Screening for amino acid substitutions in the Candida albicans erg11 protein of azole-susceptible and azoleresistant clinical isolates: New substitutions and a review of the literature. Diagnostic Microbiology and Infectious Disease 66 (4): 373\u2013384.","journal-title":"Diagnostic Microbiology and Infectious Disease"},{"issue":"11","key":"BFjphp20164_CR23","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1128\/AAC.43.11.2663","volume":"43","author":"P Marichal","year":"1999","unstructured":"Marichal, P. et al (1999) Accumulation of 3-ketosteroids induced by itraconazole in azole-resistant clinical Candida albicans isolates. Antimicrobial Agents and Chemotherapy 43 (11): 2663\u20132670.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2","key":"BFjphp20164_CR24","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/0014-5793(95)00684-2","volume":"368","author":"DC Lamb","year":"1995","unstructured":"Lamb, D.C., Corran, A., Baldwin, B.C., Kwon-Chung, J. and Kelly, S.L. (1995) Resistant P45051a1 activity in azole antifungal tolerant Cryptococcus-Neoformans from aids patients. FEBS Letters 368 (2): 326\u2013330.","journal-title":"FEBS Letters"},{"issue":"11","key":"BFjphp20164_CR25","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1128\/AAC.47.11.3653-3656.2003","volume":"47","author":"L Rodero","year":"2003","unstructured":"Rodero, L. et al (2003) G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate. Antimicrobial Agents and Chemotherapy 47 (11): 3653\u20133656.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"3","key":"BFjphp20164_CR26","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1128\/AAC.05502-11","volume":"56","author":"E Sionov","year":"2012","unstructured":"Sionov, E., Chang, Y.C., Garraffo, H.M., Dolan, M.A., Ghannoum, M.A. and Kwon-Chung, K.J. (2012) Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14alpha-demethylase (Erg11) residue critical for differential susceptibility between fluconazole\/ voriconazole and itraconazole\/posaconazole. Antimicrobial Agents and Chemotherapy 56 (3): 1162\u20131169.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"10","key":"BFjphp20164_CR27","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1128\/AAC.00316-10","volume":"54","author":"AG Warrilow","year":"2010","unstructured":"Warrilow, A.G. et al (2010) Expression, purification, and characterization of Aspergillus fumigatus sterol 14-alpha demethylase (CYP51) isoenzymes A and B. Antimicrobial Agents and Chemotherapy 54 (10): 4225\u20134234.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"9","key":"BFjphp20164_CR28","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.1128\/AAC.00185-11","volume":"55","author":"SR Lockhart","year":"2011","unstructured":"Lockhart, S.R., Frade, J.P., Etienne, K.A., Pfaller, M.A., Diekema, D.J. and Balajee, S.A. (2011) Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR\/L98H mutation in the cyp51A gene. Antimicrobial Agents and Chemotherapy 55 (9): 4465\u20134468.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"7","key":"BFjphp20164_CR29","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3201\/eid1507.090043","volume":"15","author":"SJ Howard","year":"2009","unstructured":"Howard, S.J. et al (2009) Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerging Infectious Diseases journal 15 (7): 1068\u20131076.","journal-title":"Emerging Infectious Diseases journal"},{"issue":"5","key":"BFjphp20164_CR30","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ijantimicag.2013.07.004","volume":"42","author":"N Adriaenssens","year":"2013","unstructured":"Adriaenssens, N., Coenen, S., Versporten, A. and Goossens, H. (2013) Outpatient systemic antimycotic and antifungal use in Europe: New outcome measure provides new insight. International Journal of Antimicrobial Agents 42 (5): 466\u2013470.","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"1","key":"BFjphp20164_CR31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ijantimicag.2006.09.019","volume":"29","author":"R Araujo","year":"2007","unstructured":"Araujo, R., Pina-Vaz, C. and Rodrigues, A.G. (2007) Susceptibility of environmental versus clinical strains of pathogenic Aspergillus. International Journal of Antimicrobial Agents 29 (1): 108\u2013111.","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"5","key":"BFjphp20164_CR32","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10096-007-0448-4","volume":"27","author":"S Costa-de-Oliveira","year":"2008","unstructured":"Costa-de-Oliveira, S., Pina-Vaz, C., Medon\u00e7a, D. and Gon\u00e7alves Rodrigues, A. (2008) A first Portuguese epidemiological survey of fungaemia in a university hospital. European Journal of Clinical Microbiology & Infectious Diseases 27 (5): 365\u2013374.","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"issue":"3","key":"BFjphp20164_CR33","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3109\/13693786.2010.511633","volume":"49","author":"S Costa-de-Oliveira","year":"2011","unstructured":"Costa-de-Oliveira, S. et al (2011) Genetic relatedness and antifungal susceptibility profile of Candida albicans isolates from fungaemia patients. Medical Mycology 49 (3): 248\u2013252.","journal-title":"Medical Mycology"},{"issue":"12","key":"BFjphp20164_CR34","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1007\/s10096-014-2194-8","volume":"33","author":"I Faria-Ramos","year":"2014","unstructured":"Faria-Ramos, I. et al (2014) Species distribution and in vitro antifungal susceptibility profiles of yeast isolates from invasive infections during a Portuguese multicenter survey. European Journal of Clinical Microbiology & Infectious Diseases 33 (12): 2241\u20132247.","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"issue":"4","key":"BFjphp20164_CR35","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1128\/AAC.41.4.748","volume":"41","author":"K Venkateswarlu","year":"1997","unstructured":"Venkateswarlu, K., Taylor, M., Manning, N.J., Rinaldi, M.G. and Kelly, S.L. (1997) Fluconazole tolerance in clinical isolates of Cryptococcus neoformans. Antimicrobial Agents and Chemotherapy 41 (4): 748\u2013751.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BFjphp20164_CR36","unstructured":"INFARMED Estat\u00edstica do Medicamento. (2003\u20132013) http:\/\/www.infarmed.pt\/portal\/page\/portal\/INFARMED\/MONITORIZACAO_DO_MERCADO\/OBSERVATORIO\/ESTATISTICA_DO_MEDICAMENTO , accessed 16 March 2015."},{"issue":"4","key":"BFjphp20164_CR37","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/jac\/dkq023","volume":"65","author":"N Adriaenssens","year":"2010","unstructured":"Adriaenssens, N., Coenen, S., Muller, A., Vankerckhoven, V. and Goossens, H. (2010) European surveillance of antimicrobial consumption (ESAC): Outpatient systemic antimycotic and antifungal use in Europe. Journal of Antimicrobial Chemotherapy 65 (4): 769\u2013774.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BFjphp20164_CR38","unstructured":"M, C., Medicamentos n\u00e3o sujeitos a receita m\u00e9dica (2011) http:\/\/www.ordemfarmaceuticos.pt\/xfiles\/sccontentdeployer_pt\/docs\/articlefile674.pdf , accessed 10 May 2015."},{"key":"BFjphp20164_CR39","unstructured":"hmR\/INFOMED, an\u00e1liseCEFAR (2012\u20132013). CEFAR. Resumo do estudo das Farm\u00e1cias vs Mass Market- MNSRM2013 vs 2012\u20132013."},{"issue":"2","key":"BFjphp20164_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/10647440400003972","volume":"12","author":"PA M\u00e5rdh","year":"2004","unstructured":"M\u00e5rdh, P.A., W\u00e5gstr\u00f6m, J., Landgren, M. and Holm\u00e9n, J. (2004) Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: 2. Factors that may have influenced the marked changes in sales volumes during the 1990s. Infectious Diseases in Obstetrics and Gynecology 12 (2): 99\u2013108.","journal-title":"Infectious Diseases in Obstetrics and Gynecology"},{"key":"BFjphp20164_CR41","unstructured":"Baumelou, A. and Coulomb, A. (2007) Situation de l\u2019autom\u00e9dication en France et perspectives d\u2019\u00e9volution: March\u00e9, comportements, positions des acteurs, in Paris La documentation fran\u00e7aise."}],"container-title":["Journal of Public Health Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1057\/jphp.2016.4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1057\/jphp.2016.4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1057\/jphp.2016.4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1057\/jphp.2016.4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T12:48:36Z","timestamp":1567601316000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1057\/jphp.2016.4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,11]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["BFjphp20164"],"URL":"https:\/\/doi.org\/10.1057\/jphp.2016.4","relation":{},"ISSN":["0197-5897","1745-655X"],"issn-type":[{"value":"0197-5897","type":"print"},{"value":"1745-655X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,11]]}}}